Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-effectiveness of Early Intervention in First-episode Psychosis: Economic Evaluation of the PAFIP Program at Medium and Long-term

NCT02916303 is registered in ClinicalTrials.gov with Fundación Marques de Valdecilla as lead sponsor.

NCT NCT02916303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-effectiveness of Early Intervention in First-episode Psychosis: Economic Evaluation of the PAFIP Program at Medium and Long-term
Lead sponsor
Fundación Marques de Valdecilla
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2020
Enrollment
490 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia